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Abstract
Multiphenotype genome-wide association studies (GWAS) may reveal pleiotropic genes,
which would remain undetected using single phenotype analyses. Analysis of large pedi-
grees offers the added advantage of more accurately assessing trait heritability, which can
help prioritise genetically influenced phenotypes for GWAS analysis. In this study we per-
formed a principal component analysis (PCA), heritability (h2) estimation and pedigree-
based GWAS of 37 cardiovascular disease -related phenotypes in 330 related individuals
forming a large pedigree from the Norfolk Island genetic isolate. PCA revealed 13 compo-
nents explaining >75% of the total variance. Nine components yielded statistically signifi-
cant h2 values ranging from 0.22 to 0.54 (P<0.05). The most heritable component was
loaded with 7 phenotypic measures reflecting metabolic and renal dysfunction. A GWAS of
this composite phenotype revealed statistically significant associations for 3 adjacent SNPs
on chromosome 1p22.2 (P<1x10-8). These SNPs form a 42kb haplotype block and explain
11% of the genetic variance for this renal function phenotype. Replication analysis of the
tagging SNP (rs1396315) in an independent US cohort supports the association (P =
0.000011). Blood transcript analysis showed 35 genes were associated with rs1396315
(P<0.05). Gene set enrichment analysis of these genes revealed the most enriched path-
way was purine metabolism (P = 0.0015). Overall, our findings provide convincing evidence
for a major pleiotropic effect locus on chromosome 1p22.2 influencing risk of renal dysfunc-
tion via purine metabolism pathways in the Norfolk Island population. Further studies are
now warranted to interrogate the functional relevance of this locus in terms of renal pathol-
ogy and cardiovascular disease risk.
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Author Summary
While many large genetic association studies have identified genes playing a role in com-
plex disorders, there is still concern over the amount of missing genetic heritability. With
this in mind, we have used a data reduction approach alongside pedigree-based association
to obtain highly heritable components which explain 'hidden' variance of multiphenotypes
within a large pedigree from the Norfolk Island genetic isolate. The most heritable of these
components involved 7 traits reflecting metabolic and renal functionality, association of
which locates to an intergenic region on chromosome 1p22.2. By integrating gene expres-
sion information, we identified enrichment of a purine metabolism pathway, further
strengthening the metabolic nature of the observed association. Adding additional support
to our approach, we show association of the tagging SNP (rs1396315) in an independent
US population. The findings presented here are of particular interest as they implicate
pleiotropic effect loci and newly associated biological pathways underlying cardiovascular
disease risk.
Introduction
Cardiovascular diseases (CVD) are highly prevalent conditions and are the leading cause of
morbidity and mortality in many developed nations [1]. In general, CVDs are comorbid condi-
tions that arise from several major underlying risk factor traits, e.g. excess adiposity, hyperten-
sion and dyslipidemia. These component traits, and therefore risk of CVD, are influenced to
varying degrees by inherited genetic factors. Many genome-wide association studies (GWASs)
have been conducted in recent years and have identified common genetic variants associated
with all major risk factor traits for CVD.
It is well known that risk factor traits for CVD tend to be correlated in populations suggest-
ing the presence of underlying genetic variants that affect multiple different phenotypes, i.e.
exert pleiotropic effects. GWAS analysis aimed at multiple CVD phenotypes simultaneously
may reveal such genetic loci, which could remain undetected using univariate (single) pheno-
type analysis methods. For example, a large-scale population-based GWAS of>25,000 Ameri-
cans revealed previously unrecognised variants within APOC1, BRAP and PLCG1 that may
confer pleiotropic effects on composite traits associated with CVD [2]. More recently, a GWAS
meta-analysis of 85,500 subjects identified 25 variants with pleiotropic associations to meta-
bolic syndrome traits [3]. These results support a multiple phenotype (“phenomics” based
approach) for mapping pleiotropic effect genes for CVD.
GWAS analysis of isolated populations have also been successfully utilised to map genes for
CVD traits [4–6]. Features such as founder effect, reduced genetic and environmental diversity,
as well as the availability of very large multi-generational pedigrees can offer advantages over
general population GWAS approaches [4]. For example, pedigree information can allow accu-
rate estimates of heritability to be calculated that can help prioritise genetically influenced phe-
notypes for GWAS analysis. Moreover, founder effect leading to reduced genetic heterogeneity
in isolated populations can amplify genetic effects and thus improve power to detect suscepti-
bility loci [7,8].
The Norfolk Island Health Study (NIHS) is a long running investigation of the genetics of
CVD traits in the isolated population of Norfolk Island—situated off the Australian East Coast
[9]. The Norfolk Island population was founded by a small group of European “Bounty”muti-
neers and their Polynesian wives in the late 1700s and now forms a 6000-member pedigree
spanning 11 generations [10–12]. The Norfolk Island population exhibits features such as
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genetic founder effect and admixture [13], and has high rates of heritable CVD traits such as
hypertension and obesity [9,14]. Recently, we completed pedigree-based GWASs of 37 CVD-
related traits in the Norfolk pedigree and identified a number of loci to be associated with indi-
vidual phenotypes (under review). The aim of this new study was to perform a multi-pheno-
type (or phenomics-based) GWAS in the genetic isolate of Norfolk Island in an effort to
identify novel pleiotropic effect loci influencing CVD related traits.
Results
This study focused on a well-characterised core pedigree from the Norfolk Island genetic iso-
late [14]. This core-pedigree is comprised of 330 individuals and has been measured for 37
quantitative traits as part of the NIHS to assess the genetics of CVD. The study involved princi-
pal component analysis (PCA) of all 37 traits to assess inter-correlation, and subsequent herita-
bility (h2) analysis to estimate genetic variance of resultant components. This was followed by
pedigree-based GWAS of heritable components using SNPs to identify major pleiotropic effect
loci for CVD risk phenotypes in this population.
Principle Component Analysis (PCA) of CVD traits
An ‘unsupervised’ PCA of 37 CVD related traits was conducted (trait summaries listed in S1
Table). The PCA extracted 13 composite phenotypes which together explained>75% of the
total variance (Table 1). Trait loading scores for each of these components is available in S2
Table. Heritability values for all 13 components, as well as a total combined component were
calculated. Nine components showed nominal significance with heritability estimates ranging
from 0.22–0.55 (P<0.05). After correction for multiple testing was applied only Component 3
and Component 9 remained significant (P<0.0038). Component 3 was the most heritable (h2
= 0.55) and was loaded with 7 measures related to CVD—% body fat, waist-to-hip ratio, sys-
tolic and diastolic blood pressure, creatinine, blood urea nitrogen, and uric acid. The measures
most strongly correlated with Component 3 were blood urea nitrogen (0.76), creatinine (0.74)
and uric acid (0.61) which are all kidney function markers suggesting that the Component 3
phenotype may represent renal dysfunction. The relationship between all extracted compo-
nents is displayed in Fig 1. Overlap between components is suggestive of co-morbidity among
traits as well as the possibility of genetic commonalities. The clinical relevance of the Compo-
nent 3 score was explored by comparison with the formal Framingham CVD score [15] and
showed a positive correlation (r = 0.4, P = 1.2x10-8).
GWAS of principle components
Following the PCA, we performed GWAS analysis for the 9 nominally significantly (p<0.05)
heritable components shown in Table 1. We decided to test all heritable components regardless
of multiple testing to explore the potential biological relevance of association hits. Of the 9
components only 2 showed association peaks with clusters of SNPs that exceeded the genome-
wide statistical significance threshold (P = 1.8x10-7). Fig 2A shows that Component 6—loaded
with iron and bilirubin measures—yielded the strongest association peak on chr 2q37.1
(P = 1x10-11). Analysis of the individual component traits revealed that this peak was entirely
associated with total and direct bilirubin, and maps to the well-known bilirubin metabolising
gene—UGT1A1 [16–18], Fig 2B.
The other component trait to yield a statistically significant association peak was the most
heritable component, Component 3. Fig 3 shows that the GWAS of Component 3 yielded
three associated SNPs located at chr 1p22.2 (min P = 1.3x10-9 for rs1396315), as well as a sup-
portive peak below the threshold of study-wide significance. GWAS of each of the 7 traits
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loaded into Component 3 individually did not show any significant peak at this locus (S1 Fig).
Therefore, unlike Component 6 (explained by bilirubin alone) the Component 3 hit indicated a
potential pleotropic effect locus that was further investigated.
To determine if there were any other additional independently associated variants in this
region we performed an association analysis conditioning on rs1396315. This revealed no fur-
ther associations indicating that only a single locus and resultant haplotype for Component 3 is
present in this region. Linkage disequilibrium (LD) analysis of the SNPs spanning the Compo-
nent 3 peak on chr 1p22.2 illustrated that rs1396315 tagged the associated haplotype and could
be used as the reference SNP for further analysis (Fig 4). The allele frequency of the rarer allele
(C) in the Norfolk pedigree was 0.24, which is consistent with the frequency in European popu-
lations [19]. Genotype association analysis of rs1396315 against the Component 3 score showed
that the rare allele (C) was associated with elevated Component 3 score in an additive fashion.
Locus-specific heritability estimates showed that this haplotype explained ~11% of the variation
in the Component 3 score, indicating this is a major effect locus in the Norfolk Island popula-
tion. Association analysis of rs1396315 against the individual phenotypes comprising Compo-
nent 3 indicated that the strongest association was with blood urea nitrogen (P = 0.00006),
followed by creatinine (P = 0.003) and uric acid (P = 0.005). The other traits loaded into Com-
ponent 3 were not associated with rs1396315 when analysed independently (P>0.1). This indi-
cates that the association of this SNP with Component 3 is primarily due to blood urea nitrogen,
creatinine and uric acid—potential metabolic and renal functional markers.
The region directly surrounding the association peak on chr 1p22.2 did not reveal any
known genes, with the closest, ZNF326, being ~325kb upstream (Fig 4). This led us to perform
a detailed annotation survey of the region surrounding the peak on chr 1p22.2 using
Table 1. PCA and heritability analysis of 37 quantitative traits.





Component 1 body fat, weight, waist, waist circumference, BMI, hip circumference,
DBP
7.84 21.19 21.19 0.27† 2.35e-2
Component 2 cholesterol, LDL, 2.96 8.00 29.19 0.37† 4.07e-3
Component 3 body fat, WHR, SBP, DBP, creatinine, urea, uric acid 2.60 7.02 36.22 0.55† 2.85e-
5‡
Component 4* GGT, ALT, AST (liver enzymes) 2.08 5.63 41.85 0.22 5.66e-2
Component 5 triglyceride’s, HDL, WHR, chol/HDL ratio 1.92 5.19 47.04 0.32† 1.43e-2
Component 6* iron, total bilirubin, direct bilirubin 1.80 4.85 51.89 0.40† 2.65e-2
Component 7 total protein, globin 1.57 4.23 56.12 0.46† 9.08e-3
Component 8* LDH, albumin, calcium, total protein 1.42 3.83 59.95 0.41† 2.50e-2
Component 9* Sodium, calcium, adj_al 1.39 3.75 63.70 0.53† 1.26e-
4‡
Component 10* bicarb, anions 1.16 3.12 66.82 0.14 1.18e-1
Component 11* glucose, potassium 1.14 3.08 69.91 0.08 3.33e-1
Component 12* chloride 1.05 2.83 72.73 0.02 4.35e-1
Component 13* phosphate 1.00 2.70 75.43 0.22† 3.99e-2
Component
total*
(all components) 27.91 75.43 75.43 0.23 7.15e-2
*component was normalised (log transformed in SOLAR) due to large kurtosis
†h2 signiﬁcant below nominal P<0.05
‡h2 signiﬁcant after correction for multiple testing (P<0.0038)
doi:10.1371/journal.pgen.1005593.t001
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LocusTrack [20]. LocusTrack allows the incorporation of association statistics, SNP LD infor-
mation, as well as several relevant UCSC annotation tracks, namely: evofold (bioinformatic
prediction of RNA loop folding); ENCODE ChIP-SEQ transcription factor binding sites, and
tissue specific methylation for liver and kidney (phenotypically relevant tissues) derived from
ENCODE Reduced Representation Bisulfite Sequencing (RRBS). Fig 4 shows the chr 1p22.2
region of interest and all the relevant surrounding annotation information. It is interesting to
note that while there may not be any genes directly annotated in the region, it does appear that
there are distinct areas of potential control, i.e. transcription factor binding sites and tissue spe-
cific methylation, as indicated by the multiple UCSC tracks. Another annotated track of inter-
est was that of the QTLs mapped from the rat genome database (RGB) to the human genome.
There are 4 QTL specifically mapped to the area of interest at 1p22.2, all related to metabolic
and renal dysfunction: Serum renin concentration QTL 2 (RGD:1300114); Non-insulin depen-
dent diabetes mellitus QTL 15 and 20 (RGD:71115, RGD:70204), and Renal disease susceptibil-
ity QTL 4 (RGD:619619). Additional annotation is available for the chr 1p22.2 region in the
form of a UCSC plot (S2 Fig), which contains the RGD QTL loci, and region specific informa-
tion on DNase hypersensitivity clusters, as well as listing the individual transcription factor
binding sites identified by ENCODE ChIP-SEQ. Finally, it is interesting to note that the associ-
ation peak appears to lie on top of a region of increased genomic recombination (Fig 4).
Replication analysis
To investigate replication of the association signal seen for rs1396315 with Component 3 we
utilised; a) an outgroup of the Norfolk Island cohort (n = 375) who are genetically unrelated
Fig 1. Venn diagram showing the inter-correlation and heritabilities of components extracted from the PCA of 37 quantitative traits. Relationships
between components were inferred either by variable overlap, or loadings on a component greater than 0.35. Heritability of each component is colour coded
(as per key) with the non-significant traits being coloured white.
doi:10.1371/journal.pgen.1005593.g001
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Fig 2. Manhattan plot of Chromosome 2 showing Component 6 associations. A) shows the genome-wide associations statistics with a distinct peak on
chromosome 2 for bilirubin, B) refines the location of the peak to chr2q37.1, a region containing the UDP-glucuronosyltransferase gene family well known to
metabolise bilirubin (UCSC track demonstrates the numerous isoforms). The blue dotted line indicates genome-wide significance level.
doi:10.1371/journal.pgen.1005593.g002
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(independent) to the core pedigree and for whom comparable genotype and phenotype data
was available (S3 Table), and b) a completely independent cohort of 738 individuals from a
general United States of America (USA) population (the CHDWB cohort) [21]. This cohort
had measurements available for 6 out of the 7 traits loaded into Component 3 (uric acid was
not available) as well as genotype data for rs1396315.
Due to the difficulties of finding an independent replication cohort with the exact same set
of 37 traits with which to replicate the PCA and generate Component 3 scores we had to
explore other options for replication. We decided to use a linear modelling approach to attempt
to predict individual Component 3 scores using only the 7 most heavily loaded traits for that
component from the discovery phase. The linear model as generated in the original Norfolk
Island discovery cohort is (all equations are as implemented in base R):
fit1 ¼ lmðCOMP3 WHRþ BF þ SBP þ DBP þ CREAT þ UREAþ U ACIDÞ
The values from this model showed a very strong correlation with the original Component
3 scores and provided excellent predictive value (R2 0.92, p< 2.16x10-16). The model (fit1) was
used to predict Component 3 scores in the n = 375 unrelated Norfolk Island outgroup using
the 7 traits of interest. The regression equation required slight modification for the US replica-
tion cohort because uric acid measures were missing. To do this we tested the effects of drop-
ping uric acid on the overall linear model and observed a minimal reduction in predictive value
(R2 0.91, p< 2.16x10-16), suggesting that the updated model should still yield accurate Compo-
nent 3 score prediction using only 6 trait measures. Predicted Component 3 scores were then
incorporated into their respective replication data sets for association analyses to be
performed.
Table 2 shows the results of the replication analysis. Association testing of the predicted
Component 3 score showed a direction specific trend toward association between rs1396315
and Component 3 in the unrelated Norfolk Island outgroup (P = 0.048). Furthermore, the US
replication cohort showed a significant association in the same direction as both the Norfolk
Island discovery and outgroup cohorts (p = 1.13x10-5, Table 2). Given the tight familial
Fig 3. Manhattan plot for Component 3 showing an association peak on chr 1p22.2. The red dotted line indicates the study-wideMeff significance
threshold.
doi:10.1371/journal.pgen.1005593.g003
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clustering and known founder effects of the discovery cohort it is not surprising that the effect
size for both replication cohorts drops substantially (>50%). Clearly, this effect size reduction
has impacted on the statistical significance of the associations. Nevertheless, these replication
findings provide compelling evidence for a robust association between rs1396315 and
Fig 4. LocusTrack plot showing detailed annotation information of the associated chr1p22.2 region. The significance level of association is given on
the left y axis (-log10(p-value)), while genomic recombination is displayed on the right y axis. Pairwise LD between the tagging SNP and each other SNP is
indicated by colour. In the bottom panel several relevant tracks of UCSC data are provided, including: evofold RNA loop prediction; ENCODE transcription
factor binding sites from ChIP-SEQ, and tissue specific RRBSmethylation information from liver and kidney (both relevant tissue types for the identified
phenotype).
doi:10.1371/journal.pgen.1005593.g004
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Component 3 and suggest a sample size of at least 400 unrelateds are required to detect the
effect as statistically significant (P<0.05).
Gene expression and pathways analysis
Due to the lack of functional genes in close proximity to the identified region on chromosome
1p22.2 we explored the potential of trans (distal) associations with the rs1396315 and available
gene expression data. We interrogated 1712 genetically heritable expression transcripts previ-
ously identified in the Norfolk Island population and measured in the same individuals [22].
Analysis revealed 55 significantly associated (P<0.05) transcripts, with the majority of tran-
scripts showing positive association with this SNP (S3 Fig). When annotated, 35/55 transcripts
were assigned to well documented genes of known function, with the remaining 20 residing in
regions of the genome that are less well annotated. Gene set enrichment analysis of these 35
genes identified 5 functional pathways exhibiting significant enrichment (Fig 5). The most sig-
nificantly enriched pathway was found to be that of purine metabolism (P = 0.0015), with 3
genes showing enrichment; PDE6D, GART, and NME2. This finding is interesting as previous
work in Norfolk Island reported on a set of eQTL associated genes implicated with CVD-risk
traits which also resided with the purine metabolism pathway [22].
Discussion
Many heritable CVD risk traits tend to be correlated suggesting the presence of underlying
genes acting pleiotropically to influence multiple traits. GWASs aimed at composite CVD traits
may reveal such genes, which would remain undetected using conventional single phenotype
analyses. Analysis of large pedigrees from isolated populations can offer advantages for map-
ping disease genes including the ability to estimate heritability for disease prioritisation and the
possible presence of larger effect loci. Here we conducted a study to search for pleiotropic effect
loci associated with CVD risk in the well characterized genetic isolate of Norfolk Island. We
performed PCA and heritability testing and identified a heritable component trait strongly
loaded with indices of metabolism and kidney function. We subsequently performed pedigree-
based GWAS to identify a risk haplotype on chromosome 1p22.2 that explains 11% of the vari-
ance in this composite trait. This represents a very large effect exerted by a single locus and
may reflect the fundamental importance of pleiotropic genes on this phenotype in this genetic
isolate. Because the composite phenotype was not able to be standardised for comparison in
external populations and given the unique nature of the Norfolk Island pedigree we could not
perform conventional replication analysis, instead using a proxy prediction based approach.
Replication analysis in an independent outgroup from Norfolk Island supported the associa-
tion of rs1396315 and Component 3 (P = 0.048). We also investigated trait/rs1396315 associa-
tion in a completely independent US cohort and observed significant association between the
predicted Component 3 score and rs1396315 (P = 0.000011). Additionally, the clinical rele-
vance of the Component 3 score was explored by comparison with the well-known
Table 2. Genotypic Association Analysis between rs1396315 and Component 3 in an unrelated Outgroup from Norfolk Island and an independent
replication cohort.
cohort n Ref Allele MAF Beta.est std.error t stat P-value P (one-tailed)
NI (discovery) 330 T 0.246 0.572 0.094 37.223 1.05E-09 -
NI (outgroup) 375 T 0.231 0.182 0.109 1.671 9.56E-02 4.78E-02
CHDWB 738 T 0.230 0.150 0.035 4.264 2.27E-05 1.13E-05
doi:10.1371/journal.pgen.1005593.t002
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Framingham CVD risk score [23] which showed a positive correlation indicating that the T
allele of rs1396315 is associated with increased risk of CVD in the Norfolk population.
A number of GWAS studies have reported association of loci at chromosome 1p22.2 with
CVD risk traits. Zabaneth et al., reported association of SNPs in this region to metabolic syn-
drome (including obesity) in 2554 Indian men [24]. Beck et al., reported association to liver
enzyme indices in a population of 133,653 Europeans and Asians [25]. Hasstedt et al., reported
association of chromosome 1p22.2 locus to coronary artery disease in 984 whites [26]. Addi-
tionally, several GWAS have identified SNPs within 1p22.2 associated with both obesity related
traits [27] and liver enzyme levels (gamma-glutamyl transferase) [28]. Interestingly in another
GWAS the same intergenic region of 1p22.2 was associated with atherosclerosis and coronary
artery calcification [29].
Our examination of the genomic landscape around the chromosome 1p22.2 region showed
this to be a relatively gene-poor region with no obvious candidate genes for CVD risk; the near-
est genes are ZNF326 (zinc finger protein) and BARHL2 (BarH-like homeobox 2) (Fig 4). We
are unaware of any literature indicating an association between CVD and related traits with
these genes, however a recent review implicates the role of zinc finger proteins in adipogenesis
[30], suggesting that this could be a potential target gene to follow up in further studies. Despite
the lack of gene annotation it is quite plausible that the presence of non-protein coding ele-
ments, eg. epigenetic marks, trans-acting eQTLs, or long-non-coding RNAs within this region
may be influencing genes and/or other regulatory factors at a distance.
Following this line of thought, we investigated available annotation, including that from sev-
eral pertinent UCSC tracks: evofold RNA loop prediction; ENCODE transcription factor bind-
ing sites from ChIP-SEQ, and tissue specific RRBS methylation information from liver and
kidney (both relevant tissue types for the identified phenotype). This feature based annotation
revealed important structures and control regions within, or in close proximity to, the associa-
tion peak. This includes tissue specific epigenetic markers from kidney and liver, as well as sev-
eral transcription factor binding sites (S2 Fig). While none of the transcription factor binding
sites related to the trans-eQTLs explored in our analyses, it is interesting to note that there are
several, such as FOXA1, that are directly associated with metabolism in tissues such as the
liver. FOXA1 is of particular interest as its family members have been shown to play an impor-
tant role in the differentiation of the pancreas and liver and regulate metabolism in mice [31].
Additionally, several transcription factor sites annotated directly under the association peak
Fig 5. Significantly enriched pathways identified from KEGG enrichment analysis.
doi:10.1371/journal.pgen.1005593.g005
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are known pioneer factors, meaning they can bind condensed chromatin and influence tran-
scription and potentially even methylation. We also noted that there were 4 annotated QTL
loci that have been mapped from the rat genome to the human genome (S2 Fig). While these
QTL are coarsely mapped to the human genome from rat data, it is of particular interest to
note that they are all metabolically related, and 2 are directly related to the function of the kid-
ney. All these observations provide additional support for the association of an important
pleiotropic site, associated with metabolism and kidney function, at 1p22.2
To investigate potential trans-acting mechanisms we conducted an association analysis
between the top ranking Component 3 SNPs and heritable gene expression transcripts mea-
sured in the same individuals [22]. Pathways analysis of genes encoding transcripts showing
significant association with SNPs revealed that the purine metabolism pathway was the most
significantly enriched. This is consistent with our previous study which identified enrichment
of NME1 and PAPPS1 in the purine pathway in the Norfolk Island cohort [22]. In the current
study transcripts for GART, NME2 and PDE6D were found to be associated with rs1396315.
Whereas NME1 encodes for the A isoform, NME2 encodes for the B isoform of nucleoside
diphosphate kinase (NDPK) which maintains the balance of nucleosides and high energy
nucleotides (ATP/GTP) via the reversible transfer of phosphate. Interestingly, GART plays a
central role in the de novo synthesis of nucleotides where it catalyses three of the ten steps
involved in the conversion of phosphoribosyl pyrophosphate into inosine monophosphate
[32]. Genetic variation in both GART and NME2 would have the potential to have fundamen-
tally important effects on nucleotide metabolism and homeostasis.
Modifications in the purine metabolic pathway are linked with a number of diseases includ-
ing kidney-related diseases such as hyperuricaemia and gout [33]. Combined with our previous
data there is evidence of a shift in the regulation of purine synthesis and metabolism in the
Norfolk Island cohort that may be linked with the development of renal dysfunction and asso-
ciated CVDs. Variation in PDE6D was also identified in relation to the purine pathway.
PDE6D encodes phospohdiesterase (PDE) 6δ subunit of the enzyme PDE6 that specifically
hydrolyzes cyclic GMP [34]. PDE6 is localised in rod or cone membranes of the mammalian
retina focussing research on its involvement in visual dysfunction [35]. These findings may
provide insight into the high incidence of ocular diseases, including glaucoma, in the Norfolk
Island population [36]. Interestingly there is also data indicating that GART also plays a role in
ocular development [37].
Overall, our findings provide convincing evidence for a significant pleiotropic effect locus at
chromosome 1p22.2 associated with a composite trait representing metabolic and/or renal dys-
function. This study illustrates the value of the phenomics approach in large pedigrees and
genetic isolates for identifying underlying genetic regulators of inter-correlated disease traits
that would go undetected using conventional single phenotype approaches. Further studies are
now warranted to better understand the importance of the associations in the broader popula-
tion and to more comprehensively interrogate the functional relevance of this locus in terms of
renal pathology and CVD risk more generally.
Materials and Methods
Sample/cohort collection, pedigree information and ethics
The Norfolk Island Health Study (NIHS) is well established [9,12,14,22,38]. The Norfolk Island
pedigree structure was previously outlined in Bellis et al., 2008 [39], and has recently been
updated Macgregor et al., 2010 [12]. The updated pedigree structure includes ~5700 Norfolk
Island individuals, spanning 11 generations and ~200 years. In this study we focused on a
reduced ‘core’ pedigree, meaning that individuals; a) were genetically related to the original
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founders, and b) had phenotype (S1 Table) and genotype information available. The total num-
ber of core pedigree members examined was 330 (excluding individuals under the age of 18)
and spans 4 generations at its greatest depth. The Norfolk Island 'outgroup' population used as
a validation cohort consisted of 375 individuals. These individuals are all unrelated to the core-
pedigree members as inferred by lack of presence in the pedigree, or a genetic kinship of 0. A
summary of the available phenotype data for these 375 individuals is available (S3 Table). All
individuals gave written informed consent. Ethical approval was granted prior to the com-
mencement of the study by the Griffith University Human Research Ethics Committee (ethical
approval no: 1300000485). Ethics approval and management of the NIHS has since been trans-
ferred to Queensland University of Technology.
The US CHDWB replication cohort
The replication cohort in Atlanta is the Center for Health Discovery andWell Being
(CHDWB) cohort of the Emory-Georgia Tech Predictive Health Institute [21]. Whole genome
genotypes were imputed from either Illumina OmniQuad or Illumina Core+Exome genotyping
arrays using Impute2 against the 1000 Genomes. Over 200 trait measures are available for the
cohort, at baseline and between 3 and 5 subsequent visits over a 4 year period (n = 738). Partic-
ipants are all employees of Emory University between the ages of 25 and 75 contacted at ran-
dom and representing a broad cross-section of the geography of the city of Atlanta and
socioeconomic diversity. Summarised clinical data for the seven major traits is available (S4
Table). Written informed consent for participation in genetic research was provided under the
auspices of the Institutional Review Boards of Georgia Tech and Emory University.
Multiple phenotype analysis
Baseline statistics for the core-pedigree (discovery cohort) were calculated for 37 CVD-related
measures including all the biochemical measures as well as body size and composition traits
(S1 Table). Phenotypic baseline statistics were calculated in SPSS 18.0. All 37 traits were then
subjected to Principle Component Analysis (PCA). Briefly, the PCA method is a multivariate
reduction method that is commonly used to identify latent components in highly dimensional
datasets. When applied to a set of observed variables, PCA will extract a smaller number of arti-
ficial variables (principle components) which should account for the majority of the total vari-
ance originally observed. Thus one of the major benefits of PCA is that once an underlying set
of components has been identified the data can be compressed with very little loss of informa-
tion. These component scores can then be retained and utilised in further analyses. The experi-
mental method utilised in this study is termed unsupervised in the sense that the PCA was run
across all the available CVD trait data, as opposed to selecting a subset of core CVD related
traits (such as BMI, weight, lipids, blood pressure, and insulin). All previous published studies
have utilised a more ‘supervised’ (selective) approach in this sense, and we hypothesise that
this may impact on the outcome of underlying CVD component structures. PCA was con-
ducted on 37 biochemical and anthropometric measures related to CVD. Components with
eigenvalues greater than 1 were retained; the number of significant variables loading on a com-
ponent was reduced through the implementation of orthogonal rotation (varimax). All PCA
trait loadings for each component are available (S2 Table).
Heritability analysis
The genetic analysis program SOLAR [40] was utilised to calculate heritability estimates for all
37 traits as well as the 13 defined principle components. The extended Norfolk pedigree was
used by SOLAR to estimate h2 (heritability). Both the individual and component traits were
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screened for covariant effects of age|sex interactions. All traits which SOLAR calculated as hav-
ing a high kurtosis were log transformed before calculating heritability estimates.
Genome-wide genotyping
EDTA anticoagulated venous blood samples were collected from all participants. Genomic
DNA was extracted from blood buffy coats using standard phenol-chloroform procedures
(Qiagen). Genome-wide genotyping was carried out using the Illumina Human610-Quad v1.0
beadchip. Raw data from Illumina idat files was SNP genotyped in R using the CRLMM pack-
age [41]. Genotype data then underwent QC routines using PLINK [42]. Briefly, SNP analysis
was restricted to autosomal SNPs with minor allele frequency>0.01, call rate>0.95 and
Hardy-Weinberg equilibrium testing p-value>10−5. After quality control, 590,603 SNPs were
used for association analyses. Genotype data was then exported from PLINK and imported
into the CRAN package GenABEL [43] for analysis.
Genome-wide association analysis, LD testing and genotype
association
A pedigree based GWAS analysis of the 9 heritable components was batched using custom R
scripts and the package GenABEL, using the polygenic model with age and sex interactions, as
well as genetic structure (the top 2 principal components of the complete SNP set as calculated
by KING [44]). Specifically, the polygenic model function implemented in GenABEL is capable
of estimating the narrow sense heritability of a trait (h2). The polygenic model takes into
account the fact that potentially thousands of genetic variants contribute to a trait phenotype.
The function implemented in GenABEL maximises the likelihood of the data under the poly-
genic model with covariates and reports twice negative maximum likelihood estimates and the
inverse of the variance-covariance matrix at the point of maximum likelihood. GenABEL also
estimates residuals of the trait and the inverse of the variance-covariance matrix for further use
in association analysis with the mmscore function. The polygenic model within GenABEL
implements variance components defined to account for linked major gene effects, background
polygenic effects, and environmental effects. Age and sex were included as covariates, as well as
genetic structure which was assessed by principal components analysis using the KING [44]
program. The top two components were chosen as covariates because we found that these
explained the majority of the variance in the outcomes being tested and inclusion of additional,
less informative, components only served to reduce the parsimony of the models. All heritable
transcripts were then treated as phenotypes and batched GWAS were run. The mmscore func-
tion as implemented in GenABEL was used. This function represents a mixed model approxi-
mation analysis for association between a trait and genetic polymorphism, and is specifically
designed for association testing in samples of related individuals. This allows for per SNP asso-
ciation testing using a polygenic (mixed) model approach [43]. The study-wide significance
was set based onMeff adjustment (P = 1.84x10
−7). Haplotype/LD testing was conducted in
Haploview 4.2 [45]. Exploration of the region surrounding the peak on chr 1p22.2 and integra-
tion of LD information and UCSC track data was performed using LocusTrack [20] within R.
Replication analysis
Ideally replication would be conducted on the exact same set of 37 clinical traits, and involve
generating component scores using the original coefficients. However, it is extremely difficult
to obtain a separate population with the exact same phenotype information, making this option
not possible. We ultimately have performed a linear model approach, using the 7 most highly
loaded Component 3 traits to predict the score in our replication cohorts, the unrelated
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Norfolk Island outgroup (n = 375), and the US CHDWB replication cohort (n = 738). Details
of the modelling are given in results, but overall the model was constructed from the discovery
cohort (NI core-pedigree, n = 330) using the lm (linear models) base R function:
fit1 ¼ lmðCOMP3  WHRþ BF þ SBP þ DBP þ CREAT þ UREAþ U ACIDÞ
Predictions were then made using the predict function in base R as follows:
COMP3:pred ¼ predict:lmðfit1; replication:dataÞ
Association testing of Component 3 (predicted) and rs1396315 in the replication cohorts
was performed using linear modelling, with the predicted component score as the outcome
and the genotype as the independent variable. The genotype was coded in an additive fashion:
0 (CC); 1 (CT), 2 (TT).
eQTL association analysis
The generation and list of eQTLs in the Norfolk Island cohort has previously described in detail
[22]. Blood from the same n = 330 Norfolk Island core-pedigree samples was collected and
stored at -20°C in PAXgene tubes (Qiagen, Valencia, CA). PAXgene Blood miRNA Kits kits
(Qiagen) were used to extract total RNA according to the manufacturers’ instructions and
RNA was assessed for quality using the Bioanalyzer 2100 (Agilent Technologies, Santa Clara,
CA). A total of 250ng RNA was amplified and labelled using the Illumina TotalPrep-96 RNA
Amplification Kit (Life Technologies, Grand Island, NY), according to the manufacturers’
instructions. Expression profiling was performed using the Illumina HumanHT-12 v4.0
Expression BeadChip Kit (Illumina, San Diego, CA) using 750ng of amplified RNA and follow-
ing the Whole-Genome Gene Expression Direct Hybridization Assay Guide. Array images
were scanned on the Illumina iScan and analyzed initially using the Gene Expression Module
of GenomeStudio (V2011.1). Background subtraction was applied and missing bead types were
imputed using GenomeStudio. Based on the number of expressed probes (at “detection p-val-
ues”< = 0.05), mean raw expression values across probes, and correlations (across probes)
between samples, all samples provided high quality data, except for one sample that was of
questionable quality and that was removed. Significantly expressed probes were then deter-
mined at a false discovery rate (FDR) of 5%, based on p-values generated in a binomial test on
the counts of samples in which a probe generated “detection p-values”< = 0.05 (success) and
>0.05 (failure). Subsequently, the raw expression levels of probes detecting significant expres-
sion were shifted by a constant amount so that the minimum observed value of any probe in
any sample was 1.0, followed by log2 transformation and quantile normalization. A series of
custom filters were designed to identify cis/trans eQTL’s; presence of multiple adjacent SNPs
in a peak (within +/-20Kb), a quick parse SNP/CHR location filter, a chromosome quadrants
filter, and a graphical filter (modified Manhattan Plots with kern smoothing to facilitate peak
identification) [22]. All eQTLs were defined by the 'tagging' SNP, the SNP with showed the
most significant association with the given transcript. A set of n = 2200 SNPs representing all
those within eQTL peaks which surpassed theMeff adjusted threshold (1.84x10
-7) were
extracted and used as a basis for an eQTL-centric association analysis. This analysis involved
Component 3 phenotype being run in a GWAS-based approach in GenABEL [43] using the
extracted SNP set. A short list of traits was obtained by using a relaxed significance threshold
1.0x10-2.
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